ClinicalTrials.gg
RecruitingNCT03979391OBITUpdated Sep 13, 2023

Isoelectric Focusing of Tears in Children With Radiologically Isolated or Clinically Isolated Syndrome

An interventional study of Tear collection and lumbar punction in Clinically Isolated Syndrome, Radiologically Isolated Syndrome and Multiple Sclerosis in Children, sponsored by Lille Catholic University. Recruiting at 1 site in France. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2023-09-13.

Sponsored by Lille Catholic University · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Sep 2019; still recruiting 7 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
Up to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Multiple Sclerosis by Lille Catholic University — 5 open to participants now, 5 under way, none of them phase 3. Multiple Sclerosis · Lille Catholic University.

Planned enrollment
10th of 11
20 · median 46
Started
2019
the only one that year
No phase
11 of 18
4 open now
Registered
10th of 18
by date

Among the 18 studies in Multiple Sclerosis by Lille Catholic University, this one is the 10th largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2019, is one of 11 with no phase, and was the 10th registered.

Multiple Sclerosis

3,273 studies on the registry are indexed under Multiple Sclerosis; 665 are open to participants now.

Browse Multiple Sclerosis studies →

Open to participants now

5 of the 18 studies in Multiple Sclerosis by Lille Catholic University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 434 Multiple Sclerosis studies recruiting now, 164 (38%) set no upper age limit and 214 (49%) stop at 75 or younger; 40 take children under 18; 95 take healthy volunteers.

This study: Up to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Multiple Sclerosis by Lille Catholic University, or all of them as a file.
02

Study summary

The main gold of this study is to lead a multicentric, prospective study, to evaluate the diagnostic quality of tears in children with clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS) during a longitudinal follow-up.

Read the detailed description

Multiple Sclerosis (MS) is a disease that affects the white matter of the central nervous system. In France, approximately 100,000 patients are affected. It is one of the most common neurological condition in young adults.

The presence of supernumerary oligoclonal bands (OCBs) in the cerebrospinal fluid (CSF) in comparison to the serum was established in 2017 as a criterion for temporal dissemination in MS patients. This is a predictive factor of conversion to MS in the clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS), either in children or adults.

However, the main inconvenient of OCB analysis in CSF is the requirement of a lumbar puncture, which is a traumatising technique that may raise ethical concerns especially when it has to be performed in children.

Searching for OCBs in tears, which are more accessible, may represent an attractive alternative. Some published articles studying adult populations go in this direction, but there are no data in the literature regarding children.

The main gold of this study is to lead a multicentric, prospective study, to evaluate the diagnostic quality of tears in children with clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS) during a longitudinal follow-up.

03

Conditions studied

  • Clinically Isolated Syndrome
  • Radiologically Isolated Syndrome
  • Multiple Sclerosis in Children

Browse trials for

Keywords

  • Clinically Isolated Syndrome
  • Radiologically Isolated Syndrome
  • Multiple Sclerosis
  • Children
  • Tear analysis
04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age \< 18 years old
  • from the child and the parents (at least one of the two legal guardians)
  • child covered by social security

For the RIS population:

  • asymptomatic child
  • fortuitous discovery of lesions strongly suggesting sclerosis multiple on a Magnetic resonance imaging (MRI) scan

For the CIS population:

  • child presenting a CIS in the past three months

Exclusion criteria

Exclusion Criteria:

  • patient with remitting MS
  • patient with progressive MS
  • patient with eye infection
  • patient under therapy on the day of inclusion due to the treatment of another disease than MS
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Children with CIS or RIS

    The detection of supernumerary oligoclonal bands (OCBs) in tears will be performed

    Diagnostic Test: Tear collection and lumbar punction

Interventions

  • Diagnostic testTear collection and lumbar punction

    Tear collection and lumbar punction will be performed in order to detect supernumerary oligoclonal bands

06

What researchers measure

Primary outcomes

  1. Sensitivity of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS

    To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis

    Time frame: Day 0

  2. Specificity of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS

    To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis

    Time frame: Day 0

  3. Positive predictive value of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS

    To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis

    Time frame: Day 0

  4. Negative predictive value of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS

    To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis

    Time frame: Day 0

Secondary outcomes

  1. Proportion of patients with OCBs in tears

    Time frame: day 0, one year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2019 (actual). Primary completion is estimated for Nov 2024, 62 months after the start.

Of 852 non-industry interventional studies with no phase under Multiple Sclerosis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 43. This study's planned 62 months is above that.

Counting every sponsor, half of 874 studies reached it within 21 months; a quarter within 9 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2019
First posted
Jun 7, 2019
StartActual
Sep 26, 2019
Primary completionEst.
Nov 26, 2024
CompletionEst.
Nov 26, 2024
Last update
Sep 13, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03979391
Responsible party
Sponsor
First posted
Jun 7, 2019
Start date
Sep 26, 2019
Primary completion
Nov 26, 2024 (estimated)
Completion
Nov 26, 2024 (estimated)
Last update
Sep 13, 2023

Study contacts

Lebitasy Marie Paule, PhD
Contact
Lebitasy.Marie-Paule@ghicl.net
03.20.22.57.41
Hautecoeur Patrick
principal investigator · Lille Catholic University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion